Advances are being made in understanding the pathogenesis, treatment outcomes and surveillance of Barrett oesophagus. Central obesity and age at onset of gastro-oesophageal reflux are being recognized as risk factors that have implications for screening. The persistent finding of nondysplastic Barrett oesophagus during surveillance is associated with low risk of malignant progression, whereas dysplastic Barrett oesophagus requires continued surveillance.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett’s esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC)
Systematic Reviews Open Access 29 January 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pohl, H., Sirovich, B. & Welch, H. G. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol. Biomarkers Prev. 19, 1468–1470 (2010).
Robertson, E. V. et al. Central obesity in asymptomatic volunteers is associated with increased intrasphincteric acid reflux and lengthening of the cardiac mucosa. Gastroenterology 145, 730–739 (2013).
Quante, M., Abrams, J. A. & Wang, T. C. The rapid rise in gastroesophageal junction tumors: is inflammation of the gastric cardia the underwater iceberg? Gastroenterology 145, 708–711 (2013).
Thrift, A. P., Kramer, J. R., Qureshi, Z., Richardson, P. A. & El-Serag, H. B. Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am. J. Gastroenterol. 108, 915–922 (2013).
Cook, M. B. Optimization and expansion of predictive models for Barrett's esophagus and esophageal adenocarcinoma: could a life-course exposure history be beneficial? Am. J. Gastroenterol. 108, 923–925 (2013).
Gaddam, S. et al. Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort. Gastroenterology 145, 548–553 (2013).
Shaheen, N. J. & Hur, C. Garlic, silver bullets, and surveillance upper endoscopy for Barrett's esophagus. Gastroenterology 145, 273–276 (2013).
Hvid-Jensen, F., Pedersen, L., Drewes, A. M., Sorensen, H. T. & Funch-Jensen, P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N. Engl. J. Med. 365, 1375–1383 (2011).
Gupta, M. et al. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium. Gastroenterology 145, 79–86 (2013).
Corley, D. A. et al. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology 145, 312–319 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Emmanuel Gorospe has received funding from Boston Scientific for educational activities. Kenneth Wang has received research funding from CDX Diagnostics, Covidien, CSA Medical, Fujinon, and Ninepoint Medical.
Rights and permissions
About this article
Cite this article
Gorospe, E., Wang, K. Risk stratification and surveillance in Barrett oesophagus. Nat Rev Gastroenterol Hepatol 11, 82–84 (2014). https://doi.org/10.1038/nrgastro.2013.237
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2013.237
